A one-and-done flu pill could soon be available in the U.S. The drug, called baloxavir marboxil, shortens influenza infection with a single dose.
It has earned a "priority review" from the FDA and, if approved, has the chance of hitting the market in 2019.
[Ads /]
That's right in time for the upcoming flu season.
Last year was one of the worst flu seasons for children.
[Ads /]
The drug is already available in Japan.